Folgen
Heinz Wiendl
Heinz Wiendl
University of Münster
Bestätigte E-Mail-Adresse bei uni-muenster.de
Titel
Zitiert von
Zitiert von
Jahr
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ...
The Lancet 391 (10127), 1263-1273, 2018
10812018
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis
X Montalban, R Gold, AJ Thompson, S Otero-Romero, MP Amato, ...
Multiple Sclerosis Journal 24 (2), 96-120, 2018
10222018
Ofatumumab versus teriflunomide in multiple sclerosis
SL Hauser, A Bar-Or, JA Cohen, G Comi, J Correale, PK Coyle, AH Cross, ...
New England Journal of Medicine 383 (6), 546-557, 2020
6322020
Leitlinien für Diagnostik und Therapie in der Neurologie
HC Diener, C Weimar, P Berlit, G Deuschl, C Elger, R Gold, W Hacke, ...
Thieme Verlag, 2012
5372012
Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis
S Wintterle, B Schreiner, M Mitsdoerffer, D Schneider, L Chen, ...
Cancer research 63 (21), 7462-7467, 2003
5182003
Acute disseminated encephalomyelitis: an update
T Menge, B Hemmer, S Nessler, H Wiendl, O Neuhaus, HP Hartung, ...
Archives of neurology 62 (11), 1673-1680, 2005
5022005
Blockade of PD‐L1 (B7‐H1) augments human tumor‐specific T cell responses in vitro
C Blank, J Kuball, S Voelkl, H Wiendl, B Becker, B Walter, O Majdic, ...
International journal of cancer 119 (2), 317-327, 2006
4522006
Teriflunomide and its mechanism of action in multiple sclerosis
A Bar-Or, A Pachner, F Menguy-Vacheron, J Kaplan, H Wiendl
Drugs 74, 659-674, 2014
4262014
A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape
H Wiendl, M Mitsdoerffer, V Hofmeister, J Wischhusen, A Bornemann, ...
The Journal of Immunology 168 (9), 4772-4780, 2002
4262002
Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis
CG Bien, J Bauer, TL Deckwerth, H Wiendl, M Deckert, OD Wiestler, ...
Annals of Neurology: Official Journal of the American Neurological …, 2002
4232002
Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation
C Kleinschnitz, N Schwab, P Kraft, I Hagedorn, A Dreykluft, T Schwarz, ...
Blood, The Journal of the American Society of Hematology 115 (18), 3835-3842, 2010
4052010
Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature
C Kleinschnitz, P Kraft, A Dreykluft, I Hagedorn, K Göbel, MK Schuhmann, ...
Blood, The Journal of the American Society of Hematology 121 (4), 679-691, 2013
3972013
Clinical relevance of brain volume measures in multiple sclerosis
N De Stefano, L Airas, N Grigoriadis, HP Mattle, J O’Riordan, ...
CNS drugs 28, 147-156, 2014
3942014
Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study
P Benkert, S Meier, S Schaedelin, A Manouchehrinia, Ö Yaldizli, ...
The Lancet Neurology 21 (3), 246-257, 2022
3922022
Multiple sclerosis: comparison of copolymer-1-reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells
O Neuhaus, C Farina, A Yassouridis, H Wiendl, F Then Bergh, T Dose, ...
Proceedings of the National Academy of Sciences 97 (13), 7452-7457, 2000
3822000
Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in …
B Schreiner, M Mitsdoerffer, BC Kieseier, L Chen, HP Hartung, M Weller, ...
Journal of neuroimmunology 155 (1-2), 172-182, 2004
3622004
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis
D Schafflick, CA Xu, M Hartlehnert, M Cole, A Schulte-Mecklenbeck, ...
Nature communications 11 (1), 247, 2020
3402020
How patients with multiple sclerosis acquire disability
FD Lublin, DA Häring, H Ganjgahi, A Ocampo, F Hatami, J Čuklina, ...
Brain 145 (9), 3147-3161, 2022
3272022
Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society
N Melzer, T Ruck, P Fuhr, R Gold, R Hohlfeld, A Marx, A Melms, ...
Journal of neurology 263, 1473-1494, 2016
3272016
The role of regulatory T cells in multiple sclerosis
AL Zozulya, H Wiendl
Nature clinical practice Neurology 4 (7), 384-398, 2008
3192008
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20